Assessing and selecting a living kidney donor;Estudio y selección del donante vivo de riñón

Nefrologia

Volumn 30, Issue SUPPL. 2, 2010, Pages 47-59

  Govantes, Miguel Ángel Gentil ^a   Palomo, Porfirio Pereira ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; DONOR SELECTION; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION TEST; KIDNEY TRANSPLANTATION; LIVING DONOR; METHODOLOGY; PRACTICE GUIDELINE;

ALGORITHMS; DONOR SELECTION; HUMANS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; LIVING DONORS;

EID: 78851471107     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2010.Nov.10691     Document Type: Article

References (55)

1. Kasiske BL, Ravenscraft M, Ramos L, Gaston RS, Bla MJ, et al. The evaluation of living renal transplant donors: Clinical practice guidelines. J Am Soc Nephrol 1996;7:2288-90.
2. European Best Practice Guidelines for Renal Transplantation.II3 Living kidney donation. EBPG Expert Group on Renal Transplantation. Nephrol Dial Transpl 2000;15(Suppl 7):47-51.
3. British Transplant Society and the British Renal Association: United Kingdom Guidelines for Living Donor Kidney Transplantation, April 2005. www.bts.org.uk. http://bts.demo.eibs.co.uk/transplantation/standards-and-guidelines. ültimo acceso: 27 de abril de 2010.
4. The Canadian Council for Donation and Transplantation. Enhancing Living Donation: A Canadian Forum, February 2006. www.ccdt.ca. Último acceso: 27 de abril de 2010.
5. CARI. Caring for Australasian with renal impairment. Live kidney donor guidelines.2010. www.nhmrc.gov.au/publications/subjects/organ.htm. Último acceso: 27 de abril de 2010.
6. Davis CL. Evaluation of the living kidney donor: Current perspectives. Am J Kidney Dis 2004;43:508-30.
7. Pham PC, Wilkinson AH, Pham PT. Evaluation of the potential living kidney donor. Am J Kidney Dis 2007;50:1043-51.
8. Felipe C, Oppenheimer F, Plaza JJ. Trasplante renal de donante vivo: una opción terapéutica real. Nefrologia 2000;20:8-21.
9. Gutiérrez-Dalmau A, Saurina A, Faura A. Valoración de los candidatos a trasplante renal de donante vivo. Arch Esp Urol 2005;8:503-10.
10. Díaz JM, Guirado LI, Facundo C, García-Maset R, Solà R. Estudio del donante vivo renal. Análisis de la patología extrarrenal como límite a la donación. Nefrologia 2005;25(Supl 2):51-6.
11. Delmonico F, Council of the Transplantation Society. A Report of the Amsterdam Forum On the Care of the Live Kidney Donor: Data and Medical Guidelines. Transplantation 2005;79(6 Suppl):S53-66.
12. Lumsdaine JA, Wigmore SJ, Forsythe JLR. Live kidney donor assessment in UK and Ireland. Br J Surg 1999;86:877-81.
13. Gabolde M Herve C, Moulin AM. Evaluation, selection and follow-up of live kidney donors: a review of current practice in French renal transplant centres. Nephrol Dial Transpl 2001;16:2048-52.
14. Mandelbrot DA, Pavlakis M, Danovitch GM, Johnson SR, Karp SJ, et al. The medical evaluation of living kidney donors: a survey of US transplant centers. Am J Transplant 2007;7:2333-43.
15. Reese P P, Feldman HI, McBride MA, Anderson K, Asch DA, et al. Substantial variation in the acceptance of medically complex live kidney donors across US renal transplant centers. Am J Transplant 2008;8:2062-70.
16. Ommen ES, Winston JA, Murphy B. Medical risks in living kidney donors: absence of proof is not proof of absence. Clin J Am Soc Nephrol 2006;1:885-95.
17. Ibrahim HN, Foley R, Tan L, Rogers T, Bailey RF, et al. Long-term consequences of kidney donation. N Engl J Med 2009;360:459-69.
18. Segev DL, Muzaale AD, Caffo BS, Mehta SH, Singer AL, et al. Perioperative mortality and long-term survival following live kidney donation. JAMA 2010;303:959-66.
19. Garg AX, Muirhead N, Knoll G, Yang RC, Prasad G V, et al. Nephrectomy Outcomes Research (DONOR) Network. Proteinuria and reduced kidney function in living kidney donors: A systematic review, meta-analysis, and meta-regression. Kidney Int 2006;70:1801-10.
20. Boudville N, Prasad GV, Knoll G, Muirhead N, Thiessen-Philbrook H, et al. Donor Nephrectomy Outcomes Research (DONOR) Network. Meta-analysis: risk for hypertension in living kidney donors. Ann Intern Med 2006;145:185-96.
21. Young A, Storsley L, Garg AX, Treleaven D, Nguan CY, et al. Health outcomes for living kidney donors with isolated medical abnormalities: a systematic review. Am J Transplant 2008;8:1878-90.
22. Sierra A, Gorostidi M, Marín R, Redón J, Banegas JR, et al. Evaluación y tratamiento de la hipertension en España. Documento de consenso. Med Clin (Barc) 2008;131:104-16.
23. Textor S, Taler S. Expanding criteria for living kidney donors: what are the limits? Transplant Rev (Orlando) 2008;22:187-91.
24. Textor SC, Taler SJ, Driscoll N, Larson TS, Gloor J, Griffin M, et al. Blood pressure and renal function after kidney donation from hypertensive living donors. Transplantation 2004;78:276-82.
25. Heimbach JK, Taler SJ, Prieto M, Cosío FG, Textor SC, et al. Obesity in living kidney donors: clinical characteristics and outcomes in the era of laparoscopic donor nephrectomy. Am J Transplant 2005;5:1057-64.
26. Reese P P, Feldman HI, Asch DA, Thomasson A, Shults J, et al. Short-term outcomes for obese live kidney donors and their recipients. Transplantation 2009;88:662-71.
27. Issa N, Meyer KH, Arrigain S, Choure G, Fatica RA, et al. Evaluation of creatinine-based estimates of glomerular filtration rate in a large cohort of living kidney donors. Transplantation 2008;86:223-30.
28. Alcázar R, Albalate M. Nuevas fórmulas para estimar el filtrado glomerular. Hacia una mayor precisión en el diagnóstico de la enfermedad renal crónica. Nefrologia 2010;30:143-6.
29. Stevens LA, Levey AS. Measured GFR as a Confirmatory Test for Estimated GFR. J Am Soc Nephrol 2009;20:2305-13.
30. Shokeir AA, Gad HM, El-Diasty T. Role of radioisotope renal scans in the choice of nephrectomy side in live kidney donors. J Urol 2003;170:373-6.
31. Grassi G, Abdelkawy H, Barsotti M, Paleologo G, Tregnaghi C, et al. Living kidney transplantation: evaluation of renal function and morphology of potential donors. Transplant Proc 2009;41:1121-4.
32. Herts BR, Sharma N, Lieber M, Freire M, Goldfarb DA, et al. Estimating glomerular filtration rate in kidney donors: a model constructed with renal volume measurements from donor CT scans. Radiology 2009;252:109-16.
33. Gluecker TM, Mayr M, Schwarz J, Bilecen D, Voegele T, et al. Comparison of CT angiography with MR angiography in the preoperative assessment of living kidney donors. Transplantation 2008;86:1249-56.
34. Türkvatan A, Akinci S, Yildiz S, Olçer T, Cumhur T. Multidetector computed tomography for preoperative evaluation of vascular anatomy in living renal donors. Surg Radiol Anat 2009;31:227-35.
35. Blondin D, Lanzman R, Schellhammer F, Oels M, Grotemeyer D, et al. Fibromuscular dysplasia in living renal donors: Still a challenge to computed tomographic angiography. Eur J Radiol 2010;75:67-71.
36. Rule AD, Gussak HM, Pond GR, Bergstralh EJ, Stegall MD, et al. Measured and estimated GFR in healthy potential kidney donors. Am J Kidney Dis 2004;43:112-9.
37. Rook M, Bosma RJ, Van Son WJ, Hofker HS, Van der Heide JJ, et al. Nephrectomy elicits impact of age and BMI on renal hemodynamics: Lower postdonation reserve capacity in older or overweight kidney donors. Am J Transplant 2008;8:2077-85.
38. Koushik R, Garvey C, Manivel JC, Matas AJ, Kasiske BL. Persistent, asymptomatic, microscopic hematuria in prospective kidney donors. Transplantation 2005;80:1425-9.
39. Strang AM, Lockhart ME, Amling CL, Kolettis PN, Burns JR. Living renal donor allograft lithiasis: a review of stone related morbidity in donors and recipients. J Urol 2008;179:832-6.
40. Giessing M, Fuller F, Tuellmann M, Liefeld L, Slowinski T, et al. Attitude to nephrolithiasis in the potential living kidney donor: a survey of the German kidney transplant centers and review of the literature. Clin Transplant 2008;22:476-83.
41. Grotemeyer D, Voiculescu A, Iskandar F, Voshege M, Blondin D, et al. Renal cysts in living kidney transplantation: long term follow-up in 25 patients. Transplant Proc 2009;41:4047-51.
42. Srivatasta A, Kumar A, Argawai A. Donors with renal cysts: a dilemma in decision making. Transplant Proc 2003;35:30-1.
43. Ravine D, Gibson R, Walker R, Scheffield L, Kincaid-Smith P et al. Evaluation of ultrasonogrphic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 1994;343:824-7.
44. Zand MS, Strang J, Dumlao M, Rubens D, Erturk E, et al. Screening a living kidney donor for polycystic kidney disease using heavily T2-weighted MRI. Am J Kidney Dis 2001;37:612-9.
45. Pei Y. Diagnostic approach in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2006;1:1108-14.
46. Zhao X, Paterson AD, Zahirieh A, He N, Wang K, et al. Molecular diagnostics in autosomal dominant polycystic kidney disease: utility and limitations. Clin J Am Soc Nephrol 2008;3:146-52.
47. Garg AX, Prasad R, Thiessen-Philbrook HR, Li P, Melo M, et al, for the Donor Nephrectomy Outcomes Research (DONOR) Network. Cardiovascular Disease and Hypertension Risk in Living Kidney Donors: An Analysis of Health Administrative Data in Ontario, Canada. Transplantation 2008;86:399-406.
48. Hernández D, Álvarez A, Armas AM, Rufino M, Porrini E, Torres A. Síndrome metabólico y donación renal de vivo: ¿este síndrome contraindica la donación? Nefrologia 2009;29:20-9.
49. a ed.), 2004. http://www.seimc.org/grupos/gesitra/fuentes/gesitra_dyc205.doc. Último acceso: 27 de abril de 2010.
50. Fischer AS, Avery RK, and the AST Infectious Disease Community of Practice. Screening of donor and recipient prior to solid organ transplantation. Am J Transpl 2009;9(Suppl 4):S7-S18.
51. Hernández-Hernández E, Alberú J, González-Michaca L, Bobadilladel Valle M, Quiroz-Mejía RA, et al. Screening for tuberculosis in the study of the living renal donor in a developing country. Transplantation 2006;81:290-2.
52. Cung RT, Feng S, Delmonico FL. Approach to the management of allograft recipients following the detection of hepatitis B in the prospective organ donor. Am J Transplant 2001;1:185-91.
53. Sidney S, Petitti DB, Soff GA, Cundiff DL, Tolan KK, et al. Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives. Contraception 2004;70:3-10.
54. Rowley AA, Hong BA, Martin S, Jones L, Vijayan A, et al. Psychiatric disorders: are they an absolute contraindication to living donation? Prog Transplant 2009;19:128-31.
55. Rodriguez JR, Pavlakis M, Danovitch GM, Johnson SR, Karp SJ, et al. Evaluating living kidney donors: relationship types, psychosocial criteria, and consent processes at US transplant programs. Am J Transplant 2007;7:2326-32.